In stroke care, every minute counts — and this doesn’t just apply to the acute emergency response. Timely optimisation of secondary prevention measures such as lipid-lowering therapy is critical to reducing the risk of recurrent events.
Yet many NHS stroke services face delays when relying solely on laboratory lipid results, especially when patients are discharged before bloods are processed or don’t attend follow-up appointments.
Now, new clinical evidence from Imperial College Healthcare NHS Trust confirms a powerful alternative: bedside lipid testing with the CardioChek® PA analyser.
NHS Study Demonstrates Real-World Accuracy and Speed
In a recent evaluation involving 100 stroke patients, the CardioChek® PA was compared directly with lab-based lipid profiles. The study found:
-
Strong agreement with laboratory values for total cholesterol, LDL-C, HDL-C, and triglycerides
-
Results delivered in under 2 minutes from a simple finger-prick blood sample
-
Performance that meets precision standards set by the European Federation of Clinical Chemistry (EFCC)
“Precision data was deemed acceptable when assessed against EFCC criteria.”
— Imperial College Healthcare NHS Trust poster, 2024
These findings validate the CardioChek® PA as a reliable and rapid solution for point-of-care lipid testing in acute and follow-up stroke settings.
Solving Real-World Clinical Challenges
NHS stroke teams frequently highlight barriers to lipid management such as:
-
Lab turnaround times extending beyond inpatient stays
-
Missed follow-ups or uncollected results
-
Limited capacity for same-day reviews
By introducing a device like CardioChek® PA, clinicians can:
✅ Perform lipid testing at the bedside or clinic
✅ Make same-day decisions about statin initiation or adjustment
✅ Enhance compliance with NICE guidelines for early lipid review
✅ Improve the patient experience with a less invasive test
This also supports cardiology, diabetes, and vascular teams aiming to deliver more agile lipid monitoring across outpatient and community services.
A Simple Tool to Empower Smarter, Faster Care
The CardioChek® PA analyser is already used across Europe in clinical and pharmacy settings — and with NHS evidence now supporting its use in stroke care, it's the right time to evaluate its fit within your pathway.
With growing demand for integrated, proactive secondary prevention, point-of-care lipid testing can be a small change that drives a big impact.
✅ Ready to Find Out More?
We’re inviting NHS clinical and procurement teams to explore how CardioChek® PA could support your service.
📞 Call us on 02476 377210
✉️ Or email: info@bhr.co.uk
About BHR Biosynex UK
With over 35 years of diagnostic experience, we supply validated point-of-care technologies that support NHS priorities for faster, more patient-centred care.
